September 21, 2021
1 min read
Save
EMPEROR-Preserved
Issue: September 2021
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Empagliflozin (Jardiance, Boehringer Ingelheim-Eli Lilly) vs. placebo in patients with HFpEF.